Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R

Blood

Volumn 101, Issue 4, 2003, Pages 1572-1581

  He, Rong ^a   Sang, Hairong ^a   Ye, Richard D ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOXIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; PROTEIN LXA4R; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION; INFLAMMATORY DISEASE; INJURY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 0037441872     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1431     Document Type: Article

References (51)

1. Rienhoff HY Jr, Huang JH, Li XX, Liao WS. Molecular and cellular biology of serum amyloid A. Mol Biol Med. 1990;7:287-298.
2. Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 1990;20:129-147.
3. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A. 1994;91:3186-3190.
4. Kumon Y, Suehiro T, Hashimoto K, Nakatani K, Sipe JD. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol. 1999;26:785-790.
5. Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998;334:489-503.
6. Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM. Regulation of extrahepatic apolipoprotein serum amyloid A (ApoSAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of ApoSAA by cultured aortic smooth muscle cells. Scand J Immunol. 1997;46:284-291.
7. Urieli-Shoval S, Linke RP, Malzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000;7:64-69.
8. Bausserman LL, Herbert PN, Rodger R, Nicolosi RJ. Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim Biophys Acta. 1984;792:186-191.
9. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3: density, size, and apolipoprotein composition. J Biol Chem. 1986;261:9644-9651.
10. Malle E, De Beer FC. Human serum amyloidA (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26:427-435.
11. Kisilevsky R. Serum amyloid A (SAA): a protein without a function: some suggestions with reference to cholesterol metabolism. Med Hypotheses. 1991;35:337-341.
12. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res. 1995;36:1058-1065.
13. Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol. 2001;13:67-73.
14. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation. 1997;96:2914-2919.
15. Duff GW. Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol Suppl. 1994;100:9-19.
16. Badolato R, Wang JM, Murphy WJ, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994;180:203-209.
17. Xu L, Badolato R, Murphy WJ, et al. A novel biologic function of serum amyloid A: induction of T lymphocyte migration and adhesion. J Immunol. 1995;155:1184-1190.
18. Olsson N, Siegbahn A, Nilsson G. Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. Biochem Biophys Res Commun. 1999;254:143-146.
19. Su SB, Gong W, Gao JL, et al. Aseven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999;189:395-402.
20. Vallon R, Freuler F, Desta-Tsedu N, et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol. 2001;166:2801-2807.
21. Palel H, Fellowes R, Coade S, Woo P. Human serum amyloid A has cytokine-like properties. Scand J Immunol. 1998;48:410-418.
22. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun. 2000;268:405-408.
23. Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun. 1992;184:582-589.
24. Fuhlbrigge RC, Fine SM, Unanue ER, Chaplin DD. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1a cDNA. Proc Natl Acad Sci U S A. 1988;85:5649-5653.
25. He R, Tan L, Browning DD, Wang JM, Ye RD. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol. 2000;165:4598-4605.
26. Ulmer AJ, Flad HD. Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. J Immunol Methods. 1979;30:1-10.
27. Cheng G, Ueda T, Nakajima H, et al. Surfactant protein A exhibits inhibitory effect on eosinophils IL-8 production. Biochem Biophys Res Commun. 2000;270:831-835.
28. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 1983;11:1475-1489.
29. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem. 1995;25:14928-14934.
30. Xie P, Browning DD, Hay N, Mackman N, Ye RD. Activation of NF-kappa B by bradykinin through a Galpha q- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem. 2000;275:24907-24914.
31. Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL-60 cells. J Immunol. 1993;151:5704-5715.
32. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappaB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 1990;265:21128-21133.
33. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leuk Biol. 1994;56:554-558.
34. Grinstein S, Furuya W. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J Biol Chem. 1992;267:18122-18125.
35. Torres M, Hall FL, O'Neil; K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol. 1993;150:1563-1578.
36. 2+-dependent production and release of IL-8 in human neutrophils. J Immunol. 1998;161:4332-4339.
37. Yu Y, De Waele C, Chadee K. Calcium-dependent interleukin-8 gene expression in T84 human colonic epithelial cells. Inflamm Res. 2001;50:220-226.
38. Okajima F, Katada T, Ui M. Coupling of the guanine nucleotide regulatory protein to chemotactic peptide receptors in neutrophil membranes and its uncoupling by islet-activating protein, pertussis toxin. J Biol Chem. 1985;260:6761-6768.
39. Klein C, Paul JI, Sauve K, et al. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol. 1998;16:1334-1337.
40. Chiang N, Fierro IM, Gronert K, Serhan CN. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med. 2000;191:1197-1208.
41. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001;12:91-105.
42. Quehenberger O, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding: construction and analysis of chimeric N-formyl peptide receptors. J Biol Chem. 1993;268:18167-18175.
43. Marsh CB, Anderson CL, Lowe MP, Wewers MD. Monocyte IL-8 release is induced by two independent Fc gamma R-mediated pathways. J Immunol. 1996;157:2632-2637.
44. Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med. 1994;180:253-260.
45. Murphy PM, Ozcelik T, Kenney RT, Tiffany HL, McDermott D, Francke U. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem. 1992;267:7637-7643.
46. Bao L, Gerard NP, Eddy RL, Shows TB, Gerard C. Mapping genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics. 1992;13:437-440.
47. Perez HD, Holmes R, Kelly E, McClary J, Andrews WH. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene. 1992;118:303-304.
48. Gronert K, Gewirtz A, Madara JL, Serhan CN. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med. 1998;187:1285-1294.
49. Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol. 2000;164:2660-2666.
50. Jack RM, Fearon DT. Selective synthesis of mRNA proteins by human peripheral blood neutrophils. J Immunol. 1988;140:4286-4293.
51. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993;365:654-657.